Showing results (1281-1290 of 1,538) with videos related to

Sort By:
Pageof 154
Lancet (London, England)|July 31, 2023
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trialChristopher W Ryan, Catherine M Tangen, Elisabeth I Heath, et al.
European Urology Oncology|August 15, 2019
Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumJeffrey Graham, J Connor Wells, Frede Donskov, et al.
Cancer Medicine|April 18, 2017
Characterizing the outcomes of metastatic papillary renal cell carcinomaJohn Connor Wells, Frede Donskov, Anna P Fraccon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 2, 2024
Exercising and immuno-oncology treatment (ExIO): a prospective pilot study for patients with solid tumorsPaulo Gustavo Bergerot, Cristiane Decat Bergerot, Jonas Ribeiro Gomes Silva, et al.
European Urology|March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical TrialThomas Powles, Michael B Atkins, Bernard Escudier, et al.
Cancer|August 21, 2025
The impact of a geriatric assessment-guided management intervention (GAIN-S) on prognostic awareness: A randomized controlled trialCristiane Decat Bergerot, Paulo Gustavo Bergerot, Marianne Razavi, et al.
Indian Journal of Pediatrics|April 20, 2000
Poisoning in children: Indian scenarioA K Dutta, A Seth, P K Goyal, et al.
BMJ Open|March 10, 2023
Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E: a protocol for a randomised controlled trial comparing an online behavioural sleep intervention with standard care in children with Rolandic epilepsyNadia Al-Najjar, Lucy Bray, Bernie Carter, et al.
European Urology Oncology|November 3, 2022
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumChun Loo Gan, Jiaming Huang, Elizabeth Pan, et al.
Nature Medicine|September 8, 2020
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trialRobert J Motzer, Paul B Robbins, Thomas Powles, et al.
Pageof 154